Preclinical Drug 

Development Solutions

PS5_5042-已p枪(1).jpg

Preclinical CRO Support for Drug Development

We provide integrated preclinical CRO support for pharmaceutical and biotech programmes, covering translational research through to IND-enabling studies. Our capabilities include disease models, pharmacology and efficacy evaluation, PK/PD studies, and comprehensive assessment through imaging, pathology and long-term follow-up, across both small- and large-animal platforms. All studies are conducted under GLP-compliant conditions, supporting global development programmes.

Preclinical Drug Development Solutions


Pharmacodynamic Evaluation

Large Animal Models

Myocardial infarction (pig), diabetes (NHP), stroke (dog), and other clinically relevant disease models.


Small Animal Models

Xenograft tumour models, Alzheimer’s disease (transgenic mice), and inflammation models.


GLP Safety Assessment

Acute and chronic toxicity


Genotoxicity and carcinogenicity


Cardiovascular (hERG) and respiratory safety


Biomarker-based risk assessment


Pharmacokinetics & Toxicology (DMPK)

In Vitro Studies

Caco-2 permeability, CYP induction/inhibition, and metabolite profiling.


In Vivo ADME

PK/PD studies in rodents, rabbits, and non-human primates.


Toxicokinetics

Dose range finding and safety margin evaluation.

图片1(1).png

Core Capability - Preclinical R&D for Drug 

Leave your information and we will contact you.

华腾英文logo (白).png

Copyright ©️ 2022, NetEase Zhuyou(and its affiliates as applicable). All Rights Reserved.

Our Locations

Quick Links

Our Services

Follow us

Building 11-12, Block B, Lian Dong U Valley, No.29, Bishan Street, Huangpu District, Guangzhou China


Room 503, 5/F Hang Seng Castle Peak Road Building 339 Castle Peak Road Cheung Sha Wan Hong Kong

Home

LinkedIn

Preclinical Drug Development Solutions

Facebook

Twitter

Medical Device Testing In Vivo

Laboratory Sciences

phone
Email